Humana Inc. $HUM Shares Bought by Fifth Third Bancorp

Fifth Third Bancorp raised its stake in shares of Humana Inc. (NYSE:HUM) by 107.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 22,930 shares of the insurance provider’s stock after acquiring an additional 11,881 shares during the period. Fifth Third Bancorp’s holdings in Humana were worth $3,976,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Aberdeen Group plc lifted its position in Humana by 18.1% during the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock worth $72,684,000 after buying an additional 43,442 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after purchasing an additional 9,960 shares during the last quarter. Ninety One UK Ltd grew its holdings in shares of Humana by 57.2% during the 4th quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock worth $28,815,000 after purchasing an additional 40,958 shares during the period. Sustainable Insight Capital Management LLC grew its holdings in shares of Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after purchasing an additional 4,740 shares during the period. Finally, North Dakota State Investment Board acquired a new stake in shares of Humana during the 4th quarter worth about $1,517,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Piper Sandler reaffirmed a “neutral” rating and set a $254.00 target price (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. Leerink Partners increased their price objective on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research report on Thursday, April 30th. Truist Financial lifted their target price on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. The Goldman Sachs Group upped their price target on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. Finally, Morgan Stanley raised their price target on Humana from $217.00 to $249.00 and gave the stock an “underweight” rating in a research report on Thursday, June 4th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $325.87.

Humana Stock Up 3.6%

Shares of Humana stock opened at $400.51 on Friday. The company has a market capitalization of $48.09 billion, a P/E ratio of 42.84, a P/E/G ratio of 2.16 and a beta of 0.71. The company has a 50 day moving average of $354.03 and a 200 day moving average of $260.19. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the prior year, the company posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts forecast that Humana Inc. will post 9.53 EPS for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.